Through myeloid cell-specific upregulation of apoptosis inhibitor 6 (API6) or autocrine IL-6, MDSC can activate STAT3 and facilitate the immune escape of GBM cells (Del Bianco et al., 2021). The gene discussed is STAT3; the disease is glioblastoma.